• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM SYPHILIS (SYPH); SYPHILIS ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM SYPHILIS (SYPH); SYPHILIS ASSAY Back to Search Results
Model Number N/A
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/01/2019
Event Type  malfunction  
Manufacturer Narrative
The cause for the discordant (b)(6) results is unknown.Siemens healthcare diagnostics has requested the patient sample for further testing and investigation.The ifu states in the limitations section: a nonreactive test result does not exclude the possibility of exposure to or infection with (b)(6) antibodies may be undetectable in some stages of the infection and in some clinical conditions.Assay performance characteristics have not been established for the atellica im syph assay used in conjunction with other manufacturers' assays for specific (b)(6) serological markers." mdr 1219913-2019-00133 (initial result) and mdr 1219913-2019-00135 (repeat result on s/n (b)(4)) were filed for the same event.
 
Event Description
A discordant (b)(6) atellica im syphilis (syph) result was obtained for a patient sample.The patient sample was repeated on both atellica im systems on a different date and the results were (b)(6).The initial detection of treponemal antibodies at the emergency service was (b)(6).Testing on an alternate method yielded (b)(6) results.Confirmatory testing was performed.The tpha result was indeterminate and the fta result was (b)(6).The rpr result was (b)(6).Patient treatment was not altered or prescribed.There was no report of adverse health consequences due to the discordant atellica im syphilis (syph) results.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2019-00134 on july 19, 2019.09/19/2019 additional information: the patient sample was received by siemens and tested with atellica im syphilis reagent lot: 128060.The sample was also processed with a scantabodies nabt (non-specific antibody blocking tube) tube to test for non-specific interferents in a particular sample.Results: date: on (b)(6) 2019, patient id: reagent lot: neat result (index), (b)(6), 128060, 0.65 (negative).Date: on (b)(6) 2019, (b)(6): rgt lot: 128060, nabt result (index), interpretation, rep 1, 0.66, negative, rep 2, 0.69, negative, rep 3, 0.64, negative.The index of the sample did not change significantly.Based on the information provided and the results of the investigation, siemens is unable to rule out a sample specific issue.The atellica im syphilis ifu (10995422_en rev.03, 2017-12) states "the results of this assay should always be interpreted in conjunction with the patient's medical history, clinical presentation and other findings.A nonreactive test result does not exclude the possibility of exposure to or infection with syphilis.T.Pallidum antibodies may be undetectable in some stages of the infection and in some clinical conditions." based on the information provided a product problem was not identified.The instrument is performing within specifications.No further evaluation of the device is required.Mdr 1219913-2019-00133 supplemental report 1 (initial result) and mdr 1219913-2019-00135 supplemental report 1 (repeat result on s/n: (b)(6) were filed for the same event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM SYPHILIS (SYPH)
Type of Device
SYPHILIS ASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
MDR Report Key8808420
MDR Text Key166539774
Report Number1219913-2019-00134
Device Sequence Number1
Product Code LIP
UDI-Device Identifier00630414599885
UDI-Public00630414599885
Combination Product (y/n)N
PMA/PMN Number
K112343
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 10/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/19/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/10/2020
Device Model NumberN/A
Device Catalogue Number10995675
Device Lot Number63204060
Was Device Available for Evaluation? No
Date Manufacturer Received09/19/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age31 YR
-
-